Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Li, Xiaowei  [Clear All Filters]
2022
Liu Y, Li X, Zhao X, Dong J, Zhang C, Lin T. Establishment of a human iPSC (ZZUNEUi026-A) from a dilated cardiomyopathy patient carrying heterozygous Vinculin (c. 625A > T) mutant. Stem Cell Res. 2022;62:102812.
Zhao J, Wang L, Zhu K, Chen X, Qin F, Li X, Dong J, Tao H. Human induced pluripotent stem cell line ZZUNEUi027-A generated from a long QT syndrome patient with a heterozygous KCNH2 (c. 128 A > G) mutant. Stem Cell Res. 2022;63:102836.
Cheng D, Zhang S, Li X, Wang L, Dong J, Zhang H. An integration-free iPSC line ZZUNEUi028-A derived from a patient with hypertrophic cardiomyopathy carrying a heterozygous mutation (c. 1504 C > T) in MYBPC3 gene. Stem Cell Res. 2022;63:102848.
Jiang Y, Li X, Guo T, Lu W-J, Ma S, Chang Y, Song Y, Zhang S, Bai R, Wang H, et al. Ranolazine rescues the heart failure phenotype of PLN-deficient human pluripotent stem cell-derived cardiomyocytes. Stem Cell Reports. 2022.
Ding T, Zhu W, Li X, Jian L. Reprogramming of a human induced pluripotent stem cell line (ZZUSAHi004-A) from a long QT syndrome patient with a heterozygous AKAP9 (c. 4021C > A) mutant. Stem Cell Res. 2022;65:102966.
Xie C, Li X, Hei L, Chen Y, Dong Y, Zhang S, Ma S, Xu J, Pang Q, Lynch I, et al. Toxicity of ceria nanoparticles to the regeneration of freshwater planarian Dugesia japonica: The role of biotransformation. Sci Total Environ. 2022:159590.
2021
Huang S, Fu W, Guo G, Tiana X, Zhao X, Dong J, Li X, Yang H. Generation of a hiPSC line ZZUNEUi017-A from a patient with dilated cardiomyopathy caused by mutation in TTN. Stem Cell Res. 2021;52:102248.
Tian X, Fu W, Guo G, Huang S, Dong Y, Li X, Dong J, Zhao X, Zhang Y. Generation of a human iPSC line ZZUNEUi015-A from a patient with hypertrophic cardiomyopathy caused by mutation in ALPK3. Stem Cell Res. 2021;52:102247.
Guo G, Fu W, Li X, Dong J, Zhao X, Zhang Y. Generation of an iPSC line (ZZUNEUi016-A) derived from a hypertrophic cardiomyopathy patient with the heterozygote mutation in MYH7 gene. Stem Cell Res. 2021;53:102262.
Dong Y, Li X, Fu W, Tian X, Guo G, Peng Y, Zhai Y, Zhao J, Ding Z, Zhao X, et al. Generation of an iPSC line (ZZUNEUi021-A) from a hypertrophic cardiomyopathy patient with TNNT2 mutation. Stem Cell Res. 2021;58:102622.
Li X, Fu W, Guo G, Liu M, Du W, Zhao J, Liu Y, Wang L, Dong J, Zhao X. A heterozygous MYH7 (c. 2156G > A) mutant human induced pluripotent stem cell line (ZZUNEUi020-A) generated from a patient with hypertrophic cardiomyopathy. Stem Cell Res. 2021;51:102158.
Liu M, Li X, Fu W, Wang M, Liu Y, Wang L, Hu L, Zhao X, Dong J. Induced pluripotent stem cell (iPSC) line (ZZUNEUi009-A) from a healthy female individual. Stem Cell Res. 2021;53:102275.
Liu Y, Li X, Fu W, Liu M, Wang M, Hu L, Wang L, Zhao X, Ding Z, Dong J. An induced pluripotent stem cells line (ZZUNEUi022-A) derived from urine cells of healthy male human. Stem Cell Res. 2021;51:102191.
Chen S, Carlson MAlan, Li X, Siddique A, Zhu W, Xie J. Minimally Invasive Delivery of 3D Shape Recoverable Constructs with Ordered Structures for Tissue Repair. ACS Biomater Sci Eng. 2021.
2020
Li X, Liu Y, Liu F, Wang X, Liu M, Du W, Zhao J, Wang M, Hu L, Wang C, et al. Generation of a hiPSC line ZZUNEUi007-A from a patient with hypertrophic cardiomyopathy caused by mutation in MYH7. Stem Cell Res. 2020;43:101699.
Wang M, Ruan Y, Tian X, Liu Y, Liu M, Fu W, Du W, Zhao J, Hu L, Li X, et al. Generation of a hiPSC line ZZUNEUi012-A from a healthy female individual. Stem Cell Res. 2020;50:102143.
Wu F, Li X, Bai R, Li Y'nan, Gao J, Lan F. Generation of a Junctophilin-2 homozygous knockout human embryonic stem cell line (WAe009-A-36) by an episomal vector-based CRISPR/Cas9 system. Stem Cell Res. 2020;48:101930.
Wang L, Li X, Fu W, Zhang S, Du W, Zhao J, Liu M, Wang M, Liu Y, Hu L, et al. Generation of an IPSC line from a patient with hypertrophic cardiomyopathy carrying a mutation in MYH6 gene. Stem Cell Res. 2020;50:102138.
Fu W, Wang M, Liu Y, Liu M, Wang L, Hu L, Zhao X, Ding Z, Li X, Dong J. Induced pluripotent stem cell line (ZZUNEUi011-A) derived from peripheral blood mononuclear cells (PBMCs) of a healthy 27-year-old female individual. Stem Cell Res. 2020;50:102139.
Li X, Lu Y, Wang J, Liu M, Wang M, Hu L, Du W, Wang L, Jiang Z, Gu X, et al. An integration-free iPSC line ZZUNEUi008-A derived from dermal fibroblasts of a child with cardiac valvular dysplasia carrying a mutation in FLNA gene. Stem Cell Res. 2020;47:101882.
2019
Li X, Dong T, Li Y'nan, Wu F, Lan F. Generation of a human iPSC line from a patient with Marfan syndrome caused by mutation in FBN1. Stem Cell Res. 2019;36:101414.
Piejko M, Walczak P, Li X, Bulte JWM, Janowski M. In Vitro Assessment of Fluorine Nanoemulsion-Labeled Hyaluronan-Based Hydrogels for Precise Intrathecal Transplantation of Glial-Restricted Precursors. Mol Imaging Biol. 2019.
Zhou Z, Long D, Hsu C-C, Liu H, Chen L, Slavin B, Lin H, Li X, Tang J, Yiu S, et al. Nanofiber-Reinforced Decellularized Amniotic Membrane Improves Limbal Stem Cell Transplantation in a Rabbit Model of Corneal Epithelial Defect. Acta Biomater. 2019.
2016
Li X, Tzeng SY, Liu X, Tammia M, Cheng Y-H, Rolfe A, Sun D, Zhang N, Green JJ, Wen X, et al. Nanoparticle-mediated transcriptional modification enhances neuronal differentiation of human neural stem cells following transplantation in rat brain. Biomaterials. 2016;84:157-166.
2014
Li X, Liu X, Josey B, C Chou J, Tan Y, Zhang N, Wen X. Short Laminin Peptide for Improved Neural Stem Cell Growth. Stem Cells Transl Med. 2014.